Cerveau Technologies partners with Lexeo Therapeutics for use of tau imaging agent – Healio
Related Articles
Cerveau Technologies Inc. and LEXEO Therapeutics, Inc.- Sign Agreement to Provide Novel Tau Imaging Biomarker for Disease Modifier Research – Business Wire
BOSTON–(BUSINESS WIRE)–Cerveau Technologies, Inc. today announced a license agreement with LEXEO Therapeutics, Inc. (LEXEO), which will enable LEXEO to use Cerveau’s [F-18]MK-6240, an investigational imaging…
Reviewing 4D Molecular Therapeutics (NASDAQ:FDMT) & DBV Technologies (NASDAQ:DBVT) – Defense World
Posted by admin on Jun 19th, 2022 4D Molecular Therapeutics (NASDAQ:FDMT – Get Rating) and DBV Technologies (NASDAQ:DBVT – Get Rating) are both small-cap medical…
Blavatnik prizes for Computer Science awarded to doctoral fellows – The Jerusalem Post
The second annual Blavatnik Prizes for outstanding Israeli doctoral students in Computer Science were awarded on June 8 to four Ph.D. students in a ceremony…
IARPA, Ginkgo Bioworks and Draper Announce New Technologies to Detect Engineered DNA – Investing News Network
– The Intelligence Advanced Research Projects Activity (IARPA), the research and development arm of the U.S. Intelligence community, Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform…
National Imaging Technologies Week 2022: celebrating the technologists who “show us the way” to care for patients – HCA Healthcare Today
HCA Healthcare TodayHCA Healthcare TodayFollow UsArticleTAGS:Share:Each November, National Radiologic Technology Week is celebrated to recognize the vital work of imaging professionals across the nation. The…